Ovarian cancer has one of the lowest survival rates of any cancer in Australia and, unlike many other cancers, survival has only slightly improved in recent decades. This multidisciplinary stream of research is supported by key collaborators and advisors from across the Daffodil Centre, including experts in biology and translational research, epidemiology, mathematical modelling, implementation science, health economics, statistics and key stakeholders, including community partners and patient advocates.
Group members: Professor Anna DeFazio, Dr Melissa Merritt, Professor Karen Canfell, Dr Michael Caruana, Dr Kirstie McLoughlin, Dr Nicola Meagher, Dr Saima Islam, Associate Professor Carolyn Nickson, Associate Professor Natalie Taylor, and ovarian cancer survivors and experienced consumer researchers Gillian Stannard and Jacinta Frawley Werger.
Together, the team is leading research to help inform policy and improve healthcare for women with, and at risk of developing, ovarian cancer. This work is made possible by funding from the Fussell Family Foundation and the US Department of Defense, Ovarian Cancer Research Program, Ovarian Cancer Academy – Early Career Investigator Award.